Skip to main content

Advertisement

Log in

Celiac plexus block combined with 125I seeds for refractory epigastric pain from abdominal malignancies: a retrospective case–control study

  • Interventional Radiology
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the clinical efficacy of celiac plexus block (CPB) combined with 125I seeds implantation (ISI) for refractory epigastric pain from abdominal malignancies.

Methods

The data of 81 patients with refractory epigastric pain [visual analog scale (VAS) score ≥ 4] from abdominal malignancies were collected in this retrospective case–control study. Group A (n = 40) was treated with CPB alone, while Group B (n = 41) underwent CPB combined with ISI. The primary study endpoints were the VAS score, quality of life (QoL), and local tumor control (LTC) rate. The secondary endpoints were complications, progression-free survival (PFS), and overall survival (OS).

Results

The VAS scores at week 2 (T2), week 4 (T4), week 8 (T8), and week 12 (T12) in both groups were significantly lower compared with the pretreatment values (all P < 0.01). VAS scores in Group B showed a sustained decrease, especially for “mild pain” and “moderate pain,” while the VAS scores in Group A rebounded at T8 and T12 (both P < 0.01). The QoL in Group B improved significantly from T4 until T12, which better than that at T12 in Group A (all P < 0.01). The LTC rates at T8 were 35.0% and 92.7% in Groups A and B, respectively, with a significant difference (P < 0.01). Group B had a slightly lower complication rate and a slightly longer median PFS/OS than group A, but neither was statistically different (P = 0.09 and P = 0.99, respectively).

Conclusion

CPB combined with ISI performs more sustained pain relief (up to 12 weeks) compared to CPB alone, and ultimately improves the patients’ QoL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

In addition to the raw data in the manuscript, the datasets used are available from the corresponding author on Availability of data and materials.

References

  1. Lohse I, Brothers SP (2020) Pathogenesis and Treatment of Pancreatic Cancer Related Pain. Anticancer Res 40(4):1789-1796. https://doi.org/10.21873/anticanres.14133.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Cox-Martin E, Anderson-Mellies A, Borges V, Bradley C (2020) Chronic pain, health-related quality of life, and employment in working-age cancer survivors. J Cancer Surviv 14(2):179-187. https://doi.org/10.1007/s11764-019-00843-0.

    Article  PubMed  Google Scholar 

  3. Huang L, Tao F, Wang Z, Wan H, Qu P, Zheng H (2014) Combined neurolytic block of celiac and superior hypogastric plexuses for incapacitating upper abdominal cancer pain. J BUON 19(3):826-830.

    PubMed  Google Scholar 

  4. Vig S, Bhan S, Bhatnagar S (2021) Celiac Plexus Block - An Old Technique with New Developments. Pain Physician 24(5):379-398.

    PubMed  Google Scholar 

  5. Cornman-Homonoff J, Holzwanger DJ, Lee KS, Madoff DC, Li D (2017) Celiac Plexus Block and Neurolysis in the Management of Chronic Upper Abdominal Pain. Semin Intervent Radiol 34(4):376-386. https://doi.org/10.1055/s-0037-1608861.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ashlock K (2018) Celiac Plexus Block: Management of Abdominal Pain in Patients With Late-Stage Cancer. Clin J Oncol Nurs 22(6):663-665. https://doi.org/10.1188/18.CJON.663-665.

    Article  PubMed  Google Scholar 

  7. Osman SO, Horn S, Brady D, McMahon SJ, Yoosuf AB, Mitchell D, Crowther K, Lyons CA, Hounsell AR, Prise KM, McGarry CK, Jain S, O'Sullivan JM (2017) Prostate cancer treated with brachytherapy; an exploratory study of dose-dependent biomarkers and quality of life. Radiat Oncol 12(1):53. https://doi.org/10.1186/s13014-017-0792-1.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Yu W, Xie Q, Li J, Tang J, Yang W, Tao Y (2022) Salvage 125I brachytherapy for liver metastases of colorectal cancer in anatomically challenging locations after failure of systemic chemotherapy-A retrospective study. Brachytherapy 21(5):592-598. https://doi.org/10.1016/j.brachy.2022.05.006.

    Article  PubMed  Google Scholar 

  9. Jiao D, Ren K, Li Z, Shui S, Han X (2017) Clinical role of guidance by C-arm CT for 125I brachytherapy on pulmonary tumors. Radiol Med 122(11):829-836. https://doi.org/10.1007/s11547-017-0791-1.

    Article  PubMed  Google Scholar 

  10. Jiao D, Xu K, Mukhiya G, Liu Y, Wu K, Li Z, Ren J, Han X (2022) Brachytherapy Drainage Catheter and Chemotherapy for Unresectable Pancreatic Carcinoma Combined with Obstructive Jaundice. Front Oncol 12:941336. https://doi.org/10.3389/fonc.2022.941336.

    Article  PubMed  PubMed Central  Google Scholar 

  11. He X, Liu M, Zhang M, Sequeiros RB, Xu Y, Wang L, Liu C, Wang Q, Zhang K, Li C (2020) A novel three-dimensional template combined with MR-guided 125I brachytherapy for recurrent glioblastoma. Radiat Oncol 15(1):146. https://doi.org/10.1186/s13014-020-01586-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, Chwistek M, Cleeland C, Craig D, Gafford E, Greenlee H, Hansen E, Kamal AH, Kamdar MM, LeGrand S, Mackey S, McDowell MR, Moryl N, Nabell LM, Nesbit S; BCPS; O'Connor N, Rabow MW, Rickerson E, Shatsky R, Sindt J, Urba SG, Youngwerth JM, Hammond LJ, Gurski LA (2019) Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 17(8):977–1007. https://doi.org/10.6004/jnccn.2019.0038.

  13. Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL (2017) Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification System. Cardiovasc Intervent Radiol 40(8):1141-1146. https://doi.org/10.1007/s00270-017-1703-4.

    Article  CAS  PubMed  Google Scholar 

  14. Seyal AR, Gonzalez-Guindalini FD, Arslanoglu A, Harmath CB, Lewandowski RJ, Salem R, Yaghmai V (2015) Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma. Hepatology 62(4):1111-1121. https://doi.org/10.1002/hep.27915.

    Article  CAS  PubMed  Google Scholar 

  15. Sachdev AH, Gress FG (2018) Celiac Plexus Block and Neurolysis: A Review. Gastrointest Endosc Clin N Am 28(4):579-586. https://doi.org/10.1016/j.giec.2018.06.004.

    Article  PubMed  Google Scholar 

  16. Abdel-Ghaffar ME, Ismail SA, Ismail RA, Abdelrahman MM, Abuelnaga ME (2022) Comparison Between Two Volumes of 70% Alcohol in Single Injection Ultrasound-Guided Celiac Plexus Neurolysis: A Randomized Controlled Trial. Pain Physician 25(3):293-303.

    PubMed  Google Scholar 

  17. Abdelghaffar NA, El-Rahmawy GF, Elmaddawy A, El-Badrawy A (2019) Neurólise do tronco celíaco com o uso de agulha única versus agulha dupla no manejo da dor abdominal maligna: estudo randômico controlado [Single needle versus double needle celiac trunk neurolysis in abdominal malignancy pain management: a randomized controlled trial]. Braz J Anesthesiol 69(3):284-290. https://doi.org/10.1016/j.bjan.2018.12.005.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Matsumoto T, Yoshimatsu R, Osaki M, Miyatake K, Yamanishi T, Yamagami T (2022) Computed tomography-guided single celiac plexus neurolysis analgesic efficacy and safety: a systematic review and meta-analysis. Abdom Radiol (NY) 47(11):3892-3906. https://doi.org/10.1007/s00261-022-03670-7.

    Article  PubMed  Google Scholar 

  19. Mercadante S, Catala E, Arcuri E, Casuccio A (2003) Celiac plexus block for pancreatic cancer pain: factors influencing pain, symptoms and quality of life. J Pain Symptom Manage 26(6):1140-1147. https://doi.org/10.1016/j.jpainsymman.2003.04.004.

    Article  PubMed  Google Scholar 

  20. Ma JX, Jin ZD, Si PR, Liu Y, Lu Z, Wu HY, Pan X, Wang LW, Gong YF, Gao J, Zhao-shen L (2011) Continuous and low-energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth. J Exp Clin Cancer Res 30(1):35. Published 2011 Apr 2. https://doi.org/10.1186/1756-9966-30-35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Gai B, Zhang F (2018) Chinese expert consensus on radioactive 125I seeds interstitial implantation brachytherapy for pancreatic cancer. J Cancer Res Ther 14(7):1455-1462. https://doi.org/10.4103/jcrt.JCRT_96_18.

    Article  PubMed  Google Scholar 

  22. Wong GY, Schroeder DR, Carns PE, Wilson JL, Martin DP, Kinney MO, Mantilla CB, Warner DO (2004) Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 291(9):1092-1099. https://doi.org/10.1001/jama.291.9.1092.

    Article  CAS  PubMed  Google Scholar 

  23. Urits I, Jones MR, Orhurhu V, Peck J, Corrigan D, Hubble A, Andrews M, Feng R, Manchikanti L, Kaye AD, Kaye RJ, Viswanath O (2022) A Comprehensive Review of the Celiac Plexus Block for the Management of Chronic Abdominal Pain. Curr Pain Headache Rep 24(8):42. https://doi.org/10.1007/s11916-020-00878-4.

    Article  Google Scholar 

Download references

Funding

This study was funded by the Major science and technology projects of Henan Province in 2022 [grant numbers 221100310100].

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by YL, CZ, and DJ. The first draft of the manuscript was written by YL and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Dechao Jiao.

Ethics declarations

Conflict of interest

The authors have no competing interests to declare that are relevant to the content of this article.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committees of the First Affiliated Hospital of Zhengzhou University.

Informed consent

The requirement for informed consent was waived by the Ethics Committee of The First Affiliated Hospital of Zhengzhou University because of the retrospective nature of the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Zhang, C., Song, M. et al. Celiac plexus block combined with 125I seeds for refractory epigastric pain from abdominal malignancies: a retrospective case–control study. Abdom Radiol 48, 2157–2166 (2023). https://doi.org/10.1007/s00261-023-03905-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-023-03905-1

Keywords

Navigation